The global Bioresorbable Medical Material market size is predicted to grow from US$ 1646 million in 2025 to US$ 2860 million in 2031; it is expected to grow at a CAGR of 9.6% from 2025 to 2031.
The bioresorbable medical material in this report contains polylactic acid (PLA), polyglycolic acid (PGA), polysaccharides, polycaprolactone (PCL) and PLGA.
Global Bioresorbable Medical Material key players include Evonik, Corbion, DSM, Mitsui Chemicals, PCAS, etc. Global top five manufacturers hold a share over 50%.
USA is the largest market, with a share over 40%, followed by Europe and China, both have a share over 35% percent. In terms of product, PLA is the largest segment, with a share over 20%. And in terms of application, the largest application is Orthopedics, followed by Drug Delivery.
LP Information, Inc. (LPI) ' newest research report, the “Bioresorbable Medical Material Industry Forecast” looks at past sales and reviews total world Bioresorbable Medical Material sales in 2024, providing a comprehensive analysis by region and market sector of projected Bioresorbable Medical Material sales for 2025 through 2031. With Bioresorbable Medical Material sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bioresorbable Medical Material industry.
This Insight Report provides a comprehensive analysis of the global Bioresorbable Medical Material landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bioresorbable Medical Material portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Bioresorbable Medical Material market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bioresorbable Medical Material and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bioresorbable Medical Material.
This report presents a comprehensive overview, market shares, and growth opportunities of Bioresorbable Medical Material market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Polylactic Acid (PLA)
Polyglycolic Acid (PGA)
Polysaccharides
Polycaprolactone (PCL)
PLGA
Segmentation by Application:
Drug Delivery
Orthopedics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Evonik
Corbion
DSM
Mitsui Chemicals
PCAS
Poly-Med
KLS Martin
Key Questions Addressed in this Report
What is the 10-year outlook for the global Bioresorbable Medical Material market?
What factors are driving Bioresorbable Medical Material market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Bioresorbable Medical Material market opportunities vary by end market size?
How does Bioresorbable Medical Material break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook